Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC
- 15 March 2002
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 29 (1-2), 17-33
- https://doi.org/10.1016/s0731-7085(02)00022-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltrationCritical Care Medicine, 2000
- Pharmacokinetics of Meropenem in Patients with Renal Failure and Patients Receiving Renal Replacement TherapyClinical Pharmacokinetics, 2000
- Rapid and Sensitive Determination of Meropenem in Rat Plasma by High Performance Liquid ChromatographyJournal of Liquid Chromatography & Related Technologies, 1998
- The development and performance of a radioimmunoassay for the analysis of ZM 213,689, the major metabolite of meropenem—a carbapenem antibiotic—in plasma and urineJournal of Pharmaceutical and Biomedical Analysis, 1996
- The pharmacokinetics of meropenem in surgical patients with moderate or severe infectionsJournal of Antimicrobial Chemotherapy, 1995
- MeropenemDrugs, 1995
- Determination of meropenem in plasma by high–performance liquid chromatography and a microbiological methodJournal of Clinical Pharmacy & Therapeutics, 1995
- Stability of a 1.BETA.-Methylcarbapenem Antibiotic, Meropenem(SM-7338) in Aqueous Solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- The disposition and metabolic fate of14C-meropenem in manXenobiotica, 1993
- Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenemJournal of Antimicrobial Chemotherapy, 1991